subscribe to breaking news emails
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study. .